Opioids

Resource Center

Podcasts

opioids

Expert Conversations: How the Opioid Crisis Has Affected Restless Legs Syndrome Management

04/09/2022

In this podcast, Rachel Marie E. Salas, MD, leads a discussion with Charlene Gamaldo, MD, and Sharon Park, PharmD, about the obstacles the opioid crisis has presented in the treatment of restless legs...

04/09/2022

Research Summaries

Research Summary

CDC Report: Drug Overdose Deaths Stabilize in 2022, But Still Break Previous Year’s Record

03/27/2024

Anthony Calabro, MA

Nearly 108,000 Americans died of drug overdoses in 2022, surpassing the previous year’s record total, according to a CDC report. Although the official number of deaths caused by overdoses—107,941—breaks the...

03/27/2024

Research Summary

Opioid Prescription Pre-, Post-Pandemic in Patients Who Have Undergone Dental Procedures

02/09/2024

Jessica Ganga

Researchers analyzed trends in opioid prescribing for patients who have undergone dental procedures.

02/09/2024

Research Summary

Treatment for Opioid Use Disorder Before Surgery Reduces Risk of Overdose, Hospitalization

11/07/2023

Jessica Ganga

Researchers evaluated the use of opioid use disorder (OUD) medication prior to surgery in patients with OUD to determine whether the risk of overdose or complications are reduced. The findings of the study...

11/07/2023

FDA Alert

Second OTC Naloxone Nasal Spray Approved by FDA

09/28/2023

Anthony Calabro, MA

The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.

09/28/2023

FDA Alert

FDA Approves New Treatment Option for People With Opioid Use Disorder

08/01/2023

Jessica Ganga

The FDA has approved a new buprenorphine treatment option for people with opioid use disorder following clinical trials that tested its safety and efficacy.

08/01/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4